Last $4.00 USD
Change Today -0.05 / -1.23%
Volume 3.2K
As of 8:04 PM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Announces Auditor Changes

On September 30, 2014, Bovie Medical Corporation announced that as a result of the acquisition of substantially all of the assets and business of its previous registered independent public accounting firm, Kingery & Crouse PA, by Frazier & Deeter, LLC, dismissed Kingery as its registered independent public accounting firm and engaged Frazier & Deeter. The decision to dismiss Kingery was approved by the audit committee of the company's board of directors. On October 1, 2014, the audit committee approved the appointment of Frazier & Deeter as its new registered independent public accountant, and the company formally engaged Frazier & Deeter as the company's independent public accountant on October 1, 2014.

Bovie Medical Announces Management Appointments

Bovie Medical announced that it has added two experienced sales executives to its direct sales force. Todd Hornsby joins the company as Vice President of Sales, effective August 25, 2014. Todd began his career in the field with Johnson & Johnson Ethicon Endo-Surgery and Medex before spending the last 10 years at Cryolife, where he held several sales positions before being named Senior Director of U.S. Sales in 2007. Todd brings a solid mix of sales success in the field and leadership experience to the J-Plasma(R) roll-out. Craig Roberson has come on board as Eastern Regional Sales Manager, effective August 18, 2014. Craig has 22 years of medical device sales experience. Most recently, he was District Sales Manager for a line of surgical products developed by the Bard Medical Division of CR Bard.

Bovie Medical Corporation Announces Unaudited Consolidated Financial Results for the Second Quarter and Half Year Ended June 30, 2014

Bovie Medical Corporation announced unaudited consolidated financial results for the second quarter and half year ended June 30, 2014. For the quarter, sales were $6,945,000 against $6,042,000 a year ago. Loss from operations was $1,746,000 against $1,650,000 a year ago. Pre-tax loss was $332,000 against $1,673,000 a year ago. Net income attributable to common shareholders was $29,000 or $0.07 per diluted share against net loss attributable to common shareholders of $1,119,000 or $0.06 per basic and diluted share a year ago. Adjusted non-GAAP net loss was $460,000 or $0.03 per basic and diluted share against $460,000 or $0.03 per basic and diluted share a year ago. The adjusted operating loss, which excludes the previously-mentioned inventory write-down and $383,000 related to CFO transition and other charges, was $520,000 compared to an adjusted operating loss of $609,000 in the prior year which excludes the $1.0 million impact of a legal award. For the half year, sales were $13,427,000 against $11,738,000 a year ago. Loss from operations was $1,687,000 against $2,315,000 a year ago. Pre-tax loss was $9,901,000 against $2,428,000 a year ago. Net loss attributable to common shareholders was $9,782,000 or $0.55 per basic and diluted share against $1,529,000 or $0.09 per basic and diluted share a year ago. Adjusted non-GAAP net loss was $536,000 or $0.03 per basic and diluted share against $836,000 or $0.05 per basic and diluted share a year ago.

Bovie Medical Corporation to Report Q2, 2014 Results on Aug 05, 2014

Bovie Medical Corporation announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Aug 05, 2014

Bovie Medical Corporation, Q2 2014 Earnings Call, Aug 05, 2014

Bovie Medical Corporation, Q2 2014 Earnings Call, Aug 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $4.00 USD -0.05

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $39.42 USD +0.11
STAAR Surgical Co $10.84 USD -0.04
Stereotaxis Inc $1.93 USD +0.05
Vascular Solutions Inc $26.61 USD +0.33
View Industry Companies
 

Industry Analysis

BVX

Industry Average

Valuation BVX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.8x
Price/Book 7.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.